SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential-Reference-Cited by-同舟云学术

SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential

Published:2020-09 Issue:6 Volume:1 Page:100081
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Neidleman Jason,Luo Xiaoyu,Frouard Julie,Xie Guorui,Gill Gurjot,Stein Ellen S.,McGregor Matthew,Ma Tongcui,George Ashley F.,Kosters Astrid,Greene Warner C.,Vasquez Joshua,Ghosn Eliver,Lee Sulggi,Roan Nadia R.

Funder

Van Auken Private Foundation

David Henke

Program for Breakthrough Biomedical Research

Sandler Foundation

The Roddenberry Foundation

NIH DRC Center

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

2. Viral and host factors related to the clinical outcome of COVID-19;Zhang;Nature,2020

3. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19;Thevarajan;Nat. Med.,2020

4. Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19;Huang;medRxiv,2020

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations;mBio;2024-09-09

2. Age-dependent decrease of circulating T follicular helper cells correlates with disease severity in elderly patients with COVID-19;Clinical Immunology;2024-09

3. Different polarization and functionality of CD4+ T helper subsets in people with post-COVID condition;Frontiers in Immunology;2024-08-27

4. Atypical and non-classical CD45RBlo memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19;Nature Communications;2024-08-09

5. Immune checkpoint inhibitors and SARS-CoV2 infection;International Immunopharmacology;2024-08